← Back to Search

Short Chain Fatty Acid Generator

High dose for Healthy Subjects (BG Trial)

N/A
Waitlist Available
Research Sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 4 weeks
Awards & highlights

BG Trial Summary

This study is being conducted to demonstrate short chain fatty acid (SCFA), specifically butyrate, generation in stool, blood and urine in response to oral intake of ButyraGen™.

BG Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
SCFAs in stool, blood and urine samples
Secondary outcome measures
Lactulose-mannitol test for leaky gut
Questionnaire for study product tolerability

BG Trial Design

2Treatment groups
Active Control
Group I: High doseActive Control1 Intervention
Dietary supplement containing 200 mg of active ingredient tributyrin
Group II: Low doseActive Control1 Intervention
Dietary supplement containing 100 mg of active ingredient tributyrin

Find a Location

Who is running the clinical trial?

Clinical Nutrition Research Center, Illinois Institute of TechnologyLead Sponsor
53 Previous Clinical Trials
2,891 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots for participants in this research?

"Indeed, clinicaltrials.gov indicates that this trial is in the process of patient recruitment. This particular study, which was initially posted on October 19th 2022, requires 24 participants to be sourced from a single medical centre for participation."

Answered by AI

Who else is applying?

What state do they live in?
Illinois
What site did they apply to?
Clinical Nutrition Research Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
ButyraGen™, Short Chain Fatty Acids and Gut Microbiome
2022. "ButyraGen™, Short Chain Fatty Acids and Gut Microbiome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05601635.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top